Moderna, Inc. — Director's Dealing 2020

Jul 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2020-07-15

Reporting Person: NABEL ELIZABETH G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-07-15	Common Stock	M	40307	$14.22	Acquired	54651	Direct
2020-07-15	Common Stock	M	8376	$19.15	Acquired	63027	Direct
2020-07-15	Common Stock	M	10948	$19.15	Acquired	73975	Direct
2020-07-15	Common Stock	S	73975	$87.84	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-07-15	Stock Option (Right to Buy)	$14.22	M	40307	Disposed	2028-02-28	Common Stock (40307)	Direct
2020-07-15	Stock Option (Right to Buy)	$19.15	M	8376	Disposed	2026-08-10	Common Stock (8376)	Direct
2020-07-15	Stock Option (Right to Buy)	$19.15	M	10948	Disposed	2026-08-10	Common Stock (10948)	Direct

Footnotes

F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2020.

F2: This option will become fully vested and exercisable on February 28, 2019.

F3: This option is fully vested and exercisable.